Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
AssigneeThe General Hospital Corporation
InventorsBrian Seed, Babak Banapour, Charles Romeo, Waldemar Kolanus
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe General Hospital Corporation
InventorsBrian Seed, Babak Banapour, Charles Romeo, Waldemar Kolanus
Estimating the term…
Disclosed is a method of directing a cellular immune response against an HIV-infected cell in a mammal involving administering to the mammal an effective amount of therapeutic cells which express a membrane-bound, proteinaceous chimeric receptor comprising (a) an extracellular portion which includes a fragment of CD4 which is capable of specifically recognizing and binding the HIV-infected cell but which does not mediate HIV infection and (b) an intracellular portion which is capable of signalling the therapeutic cell to destroy the receptor-bound HIV-infected cell. Also disclosed are cells which express the chimeric receptors and DNA and vectors encoding the chimeric receptors.
A chimeric receptor protein comprising:
Dependencies are inferred from the claim text.